Get started
BIO-GATE AGBB

BIO-GATE AG

1.05EURD
+0.04+3.96%
As of today at 11:29 GMT
EUR
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

BIG1 fundamentals

Key facts

Market capitalization‪9.34 M‬EUR
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded2005
Employees (FY)—
CEOMarc Lloret-Grau
Websitebio-gate.de
About

Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The firm offers MicroSilver BG, which is pure elemental microporous silver additive with antimicrobial properties, as well as HyProtect, which is an ultrathin plasma coating that protects surfaces of medical implants against bacteria. Its technologies are also used to incorporate antimicrobial properties into cosmetics including industrial and consumer products. The company was founded on December 2, 2005 and is headquartered in Nuremberg, Germany.

Ownership
‪‪9.24 M‬‬
Closely held shares
‪‪8.18 M‬‬ (88.5%)
Free Float shares
‪‪1.06 M‬‬ (11.5%)
Closely held shares
‪‪8.18 M‬‬ (88.5%)
Free Float shares
‪‪1.06 M‬‬ (11.5%)
Capital structure
No data available
There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪9.34 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪1.00‬
‪2.00‬
‪3.00‬
‪4.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−32%‬
‪−29%‬
‪−26%‬
‪−23%‬
‪−20%‬
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−1.50 M‬‬
‪0.00‬
‪‪1.50 M‬‬
‪‪3.00 M‬‬
‪‪4.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
No data available
There's currently no revenue data to show for the selected period.

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Dermacosmetics and Wound Care
Veterinary
Measurement Services
Medical Technology
Industry and Hygiene
By country
Period: 2023
Germany
European Union without Germany
Abroad without the European Union

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
H1 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪900.00 K‬‬
‪‪1.80 M‬‬
‪‪2.70 M‬‬
‪‪3.60 M‬‬
Actual
Earnings
Next:Sep 3, 2025
H1 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪−0.12‬
‪−0.09‬
‪−0.06‬
‪−0.03‬
‪0.00‬
Actual

Dividends

Dividend yield, history and sustainability

No dividends
BIG1 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−1.80 M‬‬
‪‪−900.00 K‬‬
‪0.00‬
‪‪900.00 K‬‬
‪‪1.80 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
Assets
Liabilities